Evidence map›Paper›PMID 24453083›Full record

ArticleNeurology2014

Ketogenic diet for adults in super-refractory status epilepticus.

Kiran T Thakur, John C Probasco, Sara E Hocker, Kelly Roehl, Bobbie Henry, Eric H Kossoff, Peter W Kaplan, Romergryko G Geocadin, Adam L Hartman, Arun Venkatesan and 1 more

3 registry-linked trialsOpen access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Neurology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 73 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 1 pooled it
11.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01796574 nacompletednot on this map

Feasibility and Tolerability of the Ketogenic Diet in the Treatment of Refractory Status Epilepticus in a Neurointensive Care Unit.

TypeinterventionalSponsorJohns Hopkins UniversityRan2012 to 2017Enrolled15ConditionsStatus Epilepticus, Seizure, Epilepsy, Refractory Status EpilepticusArmsKetogenic diet
NCT04358835 nawithdrawnnot on this mapstarted 2020, after this paper: background citation

Keto-diet for Intubated Critical Care COVID-19 (KICC-COVID19)

TypeinterventionalSponsorJohns Hopkins UniversityRan2020 to 2021Enrolled0ConditionsCOVID-19ArmsKetogenic diet, standard of care
NCT07496749 narecruitingnot on this mapstarted 2025, after this paper: background citation

Ketogenic Diet Treatment for Super-refractory Status Epilepticus: a Multicenter, Prospective, Randomized, Controlled Trial

TypeinterventionalSponsorXuanwu Hospital, BeijingRan2025 to 2027Enrolled84ConditionsSuper-refractory Status EpilepticusArmsthe ketogenic diet, Standard Medical Therapy
3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 1 synthesis or guideline pooled it, 186 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Status epilepticus in the ICU.Intensive care medicine · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Kiran T ThakurFrom the Departments of Neurology (K.T.T., J.C.P., E.H.K., R.G.G., A.L.H., A.V., M.C.C.) and Pediatrics (E.H.K., A.L.H.), Johns Hopkins Hospital, Baltimore, MD; Department of Neurology (S.E.H.), Mayo Clinic, Rochester, MN; Department of Food and Nutrition Services (K.R.), Rush University Medical Center, Chicago, IL; Institute for Clinical and Translational Research (B.H.), Johns Hopkins University, Baltimore; Department of Neurology (P.W.K.), Johns Hopkins Bayview Medical Center, Baltimore; and Departments of Anesthesiology-Critical Care Medicine, Neurosurgery, and Medicine (R.G.G.), Johns Hopkins University School of Medicine, Baltimore, MD.
John C Probasco
Sara E Hocker
Kelly Roehl
Bobbie Henry
Eric H Kossoff
Peter W Kaplan
Romergryko G Geocadin
Adam L Hartman
Arun Venkatesan
Mackenzie C Cervenka
Mayo Clinic in Arizona · USFood and Nutrition Service · USJohns Hopkins University · USRush University Medical Center · US

Funding

Institute for Clinical and Translational ResearchUL1TR001079 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2013 to 2017
$60.1M
Futility Study of Deferoxamine Mesylate in Intracerebral Hemorrhage (i-DEF)U01NS074425 · NINDS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SELIM, MAGDY H · 2012 to 2016
$8.7M
Consequences of Cardiac Arrest: Brain InjuryR01HL071568 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI GEOCADIN, ROMERGRYKO, THAKOR, NITISH VYOMESH · 2003 to 2022
$8.4M
Institute for Clinical and Translational ResearchUL1TR000424 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2012 to 2012
$6.0M
Multimodal Detection of Early Partial Seizure OnsetsR01NS075020 · NINDS · JOHNS HOPKINS UNIVERSITY · PI JOUNY, CHRISTOPHE C · 2011 to 2014
$1.4M
NCATS NIH HHS UL1 TR000424NCATS NIH HHS UL1 TR001079NHLBI NIH HHS R01 HL071568NINDS NIH HHS R01 NS075020NINDS NIH HHS U01 NS074425
6 · The paper itself

Abstract

objectiveTo describe a case series of adult patients in the intensive care unit in super-refractory status epilepticus (SRSE; refractory status lasting 24 hours or more despite appropriate anesthetic treatment) who received treatment with the ketogenic diet (KD).

methodsWe performed a retrospective case review at 4 medical centers of adult patients with SRSE treated with the KD. Data collected included demographic features, clinical presentation, diagnosis, EEG data, anticonvulsant treatment, and timing and duration of the KD. Primary outcome measures were resolution of status epilepticus (SE) after initiation of KD and ability to wean from anesthetic agents.

resultsTen adult patients at 4 medical centers were started on the KD for SRSE. The median age was 33 years (interquartile range [IQR] 21), 4 patients (40%) were male, and 7 (70%) had encephalitis. The median duration of SE before initiation of KD was 21.5 days (IQR 28) and the median number of antiepileptic medications used before initiation of KD was 7 (IQR 7). Ninety percent of patients achieved ketosis, and SE ceased in all patients achieving ketosis in a median of 3 days (IQR 8). Three patients had minor complications of the KD including transient acidosis and hypertriglyceridemia and 2 patients ultimately died of causes unrelated to the KD.

conclusionWe describe treatment of critically ill adult patients with SRSE with the KD, with 90% of patients achieving resolution of SE. Prospective trials are warranted to examine the efficacy of the KD in adults with refractory SE. CLASSIFICATION OF EVIDENCE: This study provides Class IV evidence that for intensive care unit patients with refractory SE, a KD leads to resolution of the SE.

Indexed as

Diet, KetogenicAdultAnticonvulsantsCritical IllnessFemaleFollow-Up StudiesHumansIntensive Care UnitsMaleMiddle AgedRetrospective StudiesStatus EpilepticusTreatment OutcomeYoung AdultAnticonvulsants

Identifiers

PMID24453083
PMCPMC3945660
OpenAlexW2050104133

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.